# Pentavalent DTaP-Hep B-IPV

> **NCT00133445** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 5 (actual)

## Conditions studied

- Diphtheria
- Hepatitis B
- Poliomyelitis
- Pertussis
- Tetanus

## Interventions

- **BIOLOGICAL:** DTaP-Hep B-IPV Vaccine
- **BIOLOGICAL:** Monovalent Hep B Vaccine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00133445
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2011-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133445, "Pentavalent DTaP-Hep B-IPV". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00133445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*